BIOMAT Database Logo BIOMAT Database Logo

A synthetic pentapeptide with biological activity characteristic of the thymic hormone thymopoietin. 1979

G Goldstein, and M P Scheid, and E A Boyse, and D H Schlesinger, and J Van Wauwe

The pentapeptide arginyl-lysyl-aspartyl-valyl-tyrosine, corresponding to amino acid residues 32--36 in thymopoietin, was synthesized. In vitro, this pentapeptide induced the differentiation of murine prothymocytes to thymocytes and inhibited differentiative induction of cells of the B lineage. This combination of actions is presently unique to the parent molecule thymopoietin. In vivo, the pentapeptide reduced the high numbers of autologous rosette-forming cells normally present in the spleens of athymic mice; this also is a property of thymopoietin. These results suggest that this readily synthesized pentapeptide corresponds to an active site of thymopoietin and might serve as a therapeutic substitute for thymopoietin.

UI MeSH Term Description Entries
D007519 Isoantigens Antigens that exist in alternative (allelic) forms in a single species. When an isoantigen is encountered by species members who lack it, an immune response is induced. Typical isoantigens are the BLOOD GROUP ANTIGENS. Alloantigens,Alloantigen,Isoantigen
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D011955 Receptors, Drug Proteins that bind specific drugs with high affinity and trigger intracellular changes influencing the behavior of cells. Drug receptors are generally thought to be receptors for some endogenous substance not otherwise specified. Drug Receptors,Drug Receptor,Receptor, Drug
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000954 Antigens, Surface Antigens on surfaces of cells, including infectious or foreign cells or viruses. They are usually protein-containing groups on cell membranes or walls and may be isolated. Cell Surface Antigens,Surface Antigens,Surface Markers, Immunological,Cell Surface Antigen,Immunologic Surface Markers,Markers, Immunological Surface,Surface Antigen,Surface Markers, Immunologic,Antigen, Cell Surface,Antigen, Surface,Antigens, Cell Surface,Immunological Surface Markers,Markers, Immunologic Surface,Surface Antigen, Cell,Surface Antigens, Cell

Related Publications

G Goldstein, and M P Scheid, and E A Boyse, and D H Schlesinger, and J Van Wauwe
Conformational properties of the pentapeptide fragment [32-36] of the thymic hormone thymopoietin.
January 1984, International journal of peptide and protein research,
G Goldstein, and M P Scheid, and E A Boyse, and D H Schlesinger, and J Van Wauwe
Thymopoietin pentapeptide treatment of sarcoidosis.
November 1983, Journal of the American Academy of Dermatology,
G Goldstein, and M P Scheid, and E A Boyse, and D H Schlesinger, and J Van Wauwe
"In vitro" biological activity of a synthetic pentapeptide of myeloid cells.
January 1987, Basic and applied histochemistry,
G Goldstein, and M P Scheid, and E A Boyse, and D H Schlesinger, and J Van Wauwe
[Treatment of recurrent herpes simplex with thymopoietin-pentapeptide].
March 1984, Deutsche medizinische Wochenschrift (1946),
G Goldstein, and M P Scheid, and E A Boyse, and D H Schlesinger, and J Van Wauwe
Thymopoietin pentapeptide treatment of primary immunodeficiencies.
March 1983, Lancet (London, England),
G Goldstein, and M P Scheid, and E A Boyse, and D H Schlesinger, and J Van Wauwe
Immunokinetics of a single dose of thymopoietin pentapeptide.
January 1980, Journal of immunopharmacology,
G Goldstein, and M P Scheid, and E A Boyse, and D H Schlesinger, and J Van Wauwe
Influence of thymic hormones on mitogen-induced interferon production in lymphocytes. II. Enhancement of Con-A-induced immune interferon production by a synthetic thymopoietin pentapeptide.
January 1984, Archiv fur Geschwulstforschung,
G Goldstein, and M P Scheid, and E A Boyse, and D H Schlesinger, and J Van Wauwe
Response to thymopoietin pentapeptide in patient with DiGeorge syndrome.
January 1980, Lancet (London, England),
G Goldstein, and M P Scheid, and E A Boyse, and D H Schlesinger, and J Van Wauwe
In vitro differentiation of two surface markers for immature T cells by the synthetic pentapeptide, thymopoietin.
January 1981, Journal of immunology (Baltimore, Md. : 1950),
G Goldstein, and M P Scheid, and E A Boyse, and D H Schlesinger, and J Van Wauwe
Bioassay determinations of thymopoietin and thymic hormone levels in human plasma.
June 1977, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!